T1000	Speculation 1648 1661	indicate that
E1000	Speculation:T1000 Scope:T1001
T1001	Span 1648 2061	indicate that p16INK4a promoter hypermethylation predicts a poor 5-year survival rates for patients with resectable non-small cell lung cancer, particularly for those with early stage tumors, whereas RASSF1A promoter hypermethylation is a profound prognostic predictor for patients with locally advanced non-small cell lung cancer, suggesting an important role of RASSF1A in non-small cell lung cancer progression
T1002	Speculation 1473 1487	indicated that
E1001	Speculation:T1002 Scope:T1003
T1003	Span 1473 1634	indicated that RASSF1A promoter hypermethylation was the stronger independent predictor for survival in patients with locally advanced non-small cell lung cancer
T1004	Speculation 1980 1990	suggesting
E1002	Speculation:T1004 Scope:T1005
T1005	Span 1980 2061	suggesting an important role of RASSF1A in non-small cell lung cancer progression
